Pfizer Pricing Data Subpoenaed By GAO As Part Of Medicaid Investigation

Pfizer has until Jan. 14 to respond to the General Accounting Office's request for documents related to price reporting practices under the Medicaid drug rebate program

More from Archive

More from Pink Sheet